Identifying genes associated with Sorafenib resistance in hepatocellular carcinoma to develop risk model
{{output}}
Background: Hepatocellular carcinoma (HCC) poses a considerable global health challenge, notably due to the resistance to sorafenib therapy, which significantly impedes effective treatment strategies. This study aimed to identify... ...
